Skip to main navigation Skip to search Skip to main content

Preeclampsia: La evolución diagnóstica desde la genómica y la proteómica

Translated title of the contribution: Preeclampsia: Diagnostic evolution from genomics and proteomics
  • Evert Jiménez Cotes
  • , Lina Martínez Sánchez
  • , Natalia Vargas Grisales
  • , Camilo Agudelo Vélez
  • , Isabel Ortiz Trujillo

    Research output: Contribution to scientific journalArticle in an indexed scientific journalpeer-review

    Abstract

    Preeclampsia was defined as the presence of hypertension evidenced two blood pressure readings ≥140/90 (systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg) and proteinuria greater than 0.3 g/day after the twentieth week pregnancy in previously normotensive patients. Still the real cause is unknown, although there are some theories that suggest that a combination of environmental factors, genetic and immunological may increase susceptibility. Genomics and proteomics have been providing necessary progress in the understanding and diagnosis of new biomarkers that point to novel advances in the diagnosis, prevention and treatment of this disease.

    Translated title of the contributionPreeclampsia: Diagnostic evolution from genomics and proteomics
    Original languageSpanish
    Pages (from-to)148-153
    Number of pages6
    JournalRevista Chilena de Obstetricia y Ginecologia
    Volume78
    Issue number2
    DOIs
    StatePublished - 2013

    Fingerprint

    Dive into the research topics of 'Preeclampsia: Diagnostic evolution from genomics and proteomics'. Together they form a unique fingerprint.

    Cite this